During the course of human infection, Bordetella pertussis colonizes sequential niches in the respiratory tract that include intracellular and extracellular environments.
of the parent, the induced, and the uninduced BPRU140 were incubated individually with macrophages for 30 min. Extracellular bacteria were then killed by gentamicin. The number of viable intracellular bacteria and the internalized bacterial enzyme activity were measured over time. By 2.5 hr all samples reached a steady-state concentration of 105 bacteria per 106 macrophages. Following an initial peak of enzyme activity, adenylate cyclase values for the parent and the uninduced BPRU140 decreased to a basal level, while the values for the induced strain remained at least 3-fold greater. Therefore, compared with the persistence of enzyme in the induced strain BPRU140, the decrease in enzyme production by the parent and the uninduced BPRU140 upon entry into macrophages indicates in vivo down-modulation of gene expression. These observations support the hypothesis that sensory transduction contributes to adaptations for bacterial survival in the infected host.
Several genera of pathogenic bacteria, such as the gastrointestinal pathogens Salmonella, Yersinia, Shigella, and Listeria, invade and survive within host cells. Recent reports describing the entry and intracellular survival of Bordetellae from rabbit alveolar macrophages (1) and cultured mammalian cells (2,3) suggest at least two different niches in the host: one extracellular on the ciliated epithelium (4) and another within leukocytes (1, 5) . The recovery ofbacteria from within rabbit alveolar macrophages in vivo indicates an intracellular state during infection (1) . It is assumed that bacteria mount an adaptive response to a changing environment by the coordinate regulation ofthose genes which convey a selective advantage for survival.
The virulence factors of Bordetella pertussis, such as pertussis toxin (Ptx), filamentous hemaglutinin (Fha), fimbriae (Fim), and the adenylate cyclase (AC) toxin, are organized into a regulon. Activation of expression of the genes in this regulon is controlled by the genetic locus bvg, which encodes two proteins, BvgA and BvgS, that are members of the two-component family of bacterial sensory transduction proteins (6, 7) . In vitro coordinate regulation by bvg, a process termed phenotypic modulation, produces two distinct phenotypes (Vir+ and Vir-) in response to defined medium components. An increased concentration of MgSO4 or nicotinic acid or a decreased temperature produces a Virphenotype (8) (9) (10) (11) . Genes expressed in the Vir+ state have been termed virulence-activated genes (i.e., those encoding Ptx, Fha, and AC) and those expressed in the Vir-state have been termed virulence-repressed genes (9) . Little is known about the in vivo role of phenotypic modulation because of the inability to measure the expression of the regulated genes such as Ptx, Fha, and Fim with sufficient sensitivity and specificity in vivo in response to a changing environment. In contrast, the bvg-regulated AC, with its high specific activity, was chosen as a reporter for the bacterial response to the natural transition of B. pertussis into human macrophages.
The cya operon, responsible for the AC (Cya) and hemolytic (Hly) phenotypes, contains five genes, cyaA, -B, -C, -D, and -E (12, 13) with the genetic organization depicted in Fig.  1 . Transcription of the structural gene, cyaA, is driven by a single promoter that is dependent on bvg for expression. An additional promoter is present between cyaA and cyaB that is constitutive for the transcription of cyaB, -D, and -E (15). The gene product of cyaA is a calmodulin-stimulated, extracellular AC that also confers the hemolytic phenotype and the ability to increase cAMP in mammalian cells (16) (17) (18) . The products of the other contiguous genes cyaB, -D, and -E are required for secretion of AC (12) . In the opposite orientation to this polycistron and separated by a short, 260-base-pair intergenic region is another gene, cyaC, whose product conveys the hemolytic and invasive properties to the toxin, presumably through covalent modification of AC (19) (20) (21) .
MATERIALS AND METHODS
Bacterial Strains and Media. Escherichia coli strains used were DH5a, which is F-080dlacZA(lacZYA-argF)U169 recAl endAl hsdRJ7 (rK-mK+) supE44 A-thy-i gyrA relAl (Bethesda Research Laboratories), and SM10, which is thi, thr, leu, su111, RP4-2-Tc::Mu (22) . B. pertussis strains used were BP348, a cyaA::TnS derivative of BP338 (12, 14) ; BP536, a spontaneous naladixic acid-resistant derivative of BP338 (23); BP537, a spontaneous bvg-derivative of BP536 (23) ; and BPRU44, a cya::TnStacl derivative of BP338 (20) . BPRU176, -178, and -182 are derivatives of BP348 that contain plasmids pAMN2, -10, and -13, respectively (Fig. 1) . The conjugal transfer of plasmids from E. coli to B. pertussis was performed as described (23, 24) .
E. coli were grown in Luria-Bertani (LB) liquid or solid medium (25) 
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The publication costs of this article were defrayed in part by page charge payment. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. §1734 solely to indicate this fact. supplement of essential components required for growth (26) . Antibiotics when required were used at the following concentrations: ampicillin, 100 ,ug/ml; chloramphenicol, 34 ,ug/ml for E. coli or 10 pAg/ml for B. pertussis; and streptomycin, 300 ,g/ml. When indicated, isopropyl f3-Dthiogalactopyranoside (IPTG) was added at 250 ,ug/ml.
Plasmid Construction and DNA Manipulation. To identify the bvg-dependent regulatory region for cyaA and create tac promoter fusions, a 6.1-kilobase (kb) BamHI-Kpn I fragment that contains the gene and its promoter but lacks any upstream sequence was subcloned from pRM003 (27) and inserted into the corresponding sites of the broad-host-range cloning vectors pMMB207 and pMMB208 (28) to generate pAMN10 and pAMN2, respectively (Fig. 1) . These plasmids constitute a pair in which cyaA is in opposite orientations to the tac promoter of the expression vector, creating inducible (pAMN2) and noninducible (pAMN10) vectors. Plasmid pAMN13, which contains cyaA, its promoter, and 2.4 kb of upstream sequence spanning the intergenic region and cyaC, was created by subcloning a 2.4-kb BamHI fragment (20) into pAMN10. Plasmids derived from pUC derivatives were isolated by the alkaline hydrolysis method (29) , whereas plasmids derived from pMMB207 and pMMB208 were isolated by a boiling method (30) . Recombinant DNA manipulations were performed by standard protocols. DNAmodifying enzymes were obtained from United States Biochemical.
AC Assay. Extracellular cell-associated AC was isolated from whole bacteria as a detergent extract (31) . Production of cAMP was measured as described (32) . Units of specific enzyme activity are presented as nmol ofcAMP produced per min per mg of total protein. Samples were assayed in the presence of 2.5 ,uM calmodulin, and protein concentrations were determined by the Coomassie blue G250 method (33) .
Bacteria--Macrophage Invasion Assay. Human monocytes were isolated from buffy coats and harvested from Teflon beakers after 5-10 days and suspended at 2 x 106 per ml in RPMI-1640 medium (GIBCO) (34) . Frozen stocks of isogenic strains of B. pertussis were grown for 1-2 days on selective BG medium. Bacterial cells were harvested from the plates and resuspended in RPMI-1640 and adjusted to an OD620 of 0.5 [109 colony-forming units (cfu)/ml]. At zero time, 1 ml of the bacterial cell suspension was mixed with 1 ml of macrophages (2 x 106 per ml) and placed on a tumbler at 3TC for 30 min. Macrophages and bound bacteria were separated from unbound bacteria by centrifugation for 10 min at 800 rpm in a Beckman Accuspin centrifuge. The bacteria/ macrophage mixtures were washed three times with RPMI-1640 and resuspended in a fresh 2 ml of RPMI-1640 plus gentamicin (100 ,g/ml) to kill extracellular bacteria. Internalized bacteria were determined at timed intervals by plating serial dilutions of a macrophage lysate on BG medium. The lysate was prepared by pelleting and resuspension of a 100-,lI sample of the bacterial/macrophage mixture with phosphatebuffered saline containing 0.1% Triton X-100.
Determination of the Internalized Bacterial AC Activity.
Trypsin treatment has been shown to completely destroy any bacteria-associated AC activity (31) . Thus to distinguish AC activity derived from internalized bacteria from that of extracellular bacteria, samples of the bacteria/macrophage suspension were treated with trypsin to destroy any enzyme activity outside the macrophage. Samples from the bacteria/ macrophage mixture were removed at timed intervals, adjusted to a final trypsin concentration of 20 ,ug/ml, and incubated for 10 min at 37°C. After a 5-min incubation with a 20 molar excess of soybean trypsin inhibitor, the macrophages were lysed as described above, and the samples were frozen and subsequently assayed for AC activity. AC activity measured in the macrophage lysates was derived from the bacteria and not the endogenous eukaryotic enzyme since enzyme activity in a lysate of macrophages challenged with a cya-strain, BPRU44, was three log units less than with the Cya+ strains (data not shown). expressed AC activity in a bvg-dependent manner, but downmodulation could be overcome by the addition of IPTG (Fig.  2) . One hour following addition of40 mM MgSO4, AC activity of BPRU140 decreased to a basal level that remained constant over 4 hr (i.e., one generation time). This time course of down-modulation was identical to that of the parental strain BP536 and is consistent with bvg-dependent downmodulation of AC expression measured at the level of transcription (37) . In contrast, AC activity remained 4-fold higher in BPRU140 when induced with IPTG, despite the presence of 40 (Fig. 3) . Therefore, the bvg- were removed at timed intervals, centrifuged, and suspended in 0.1% Triton X-100 to solubilize the extracellular associated enzyme.
RESULTS AND DISCUSSION
Samples were centrifuged again to remove whole cells and the supernatants were assayed for enzyme activity (26, 32) (1992) pertussis modulates expression of AC upon entry into human macrophages, bacterial AC enzyme activity was monitored in parallel with bacterial invasion and survival in macrophages. Three samples were studied. (i) The parent strain, BP536, which contains only a bvg-regulated chromosomal copy of cyaA, was compared with two controls. (ii) BPRU140, which contains an IPTG-inducible plasmid-borne copy of cyaA in a wild-type background, was assayed as a positive control to assess induced AC production independent ofbvg. (iii) Killed BP536 was assayed as a negative control to establish basal AC activity associated with internalized bacteria not actively producing the enzyme. Bacterial AC activity within the macrophage was assessed by destroying extracellular enzyme with trypsin and liberation of the internalized bacterial enzyme by lysis of the macrophages that contained ingested bacteria. Intracellular bacteria invasion and survival were defined as colony-forming units obtained following gentamicin treatment of a bacteria/macrophage mixture.
The parental strain (BP536) and BPRU140 bound macrophages in a ratio of 10:1 (107 bacteria per 106 macrophages per ml; Fig. 4A ). After the addition of gentamicin (100 ,ug/ml), bacterial killing progressed until a steady-state concentration of 105 bacteria per ml was reached by 2.5 hr. Bacteria refractory to the bactericidal activity of gentamicin after 2.5 hr were taken to represent the intracellular pool of bacteria. Similar results were obtained with polymixin B (100 &g/ml) (data not shown). Ninety-five percent of the macrophages remained viable during the course of the experiment as determined by visual examination for trypan blue exclusion. Induction of cyaA with IPTG in the mutant strain BPRU140 did not affect the survival of these bacteria. To kill the bacteria prior to incubation with the macrophages, a sample of BP536 was pretreated for 2 hr with gentamicin at 100 ,ug/ml. This led to a four-log reduction of surviving bacteria compared with bacteria that were not pretreated. The bvgstrain BP537 does not express any known virulence determinant. This strain bound less avidly to macrophages than the bvg+ strains (2 x 105 cfu/ml vs. 1 x 107 cfu/ml). Those that were bound did not survive treatment with gentamicin and macrophage challenge (103 cfu/ml). This is consistent with other studies describing the inability of avirulent strains to attach to human macrophages (38) or invade other cells (2, 3). Bacterial multiplication in any strain was not observed over the 4-hr time course of the experiment. This is not unexpected given the 4-to 6-hr doubling time observed for the growth of B. pertussis in liquid medium (Fig. 3) . There (Fig. 4B) . When the AC values were plotted as a function ofactivity per colony-forming unit over time (Fig. 5) Fig. 4 . Units of AC specific activity (nmol of cAMP per min per mg of protein) from the experiment depicted in Fig. 4 are plotted as a function of cfu over time. The parent BP536 (-) was compared with isogenic BPRU140 (BP536 carrying the plasmid-borne, IPTG-inducible cyaA) treated (e) or untreated (o) with 250 .uM IPTG. transition to inside the macrophage is presumably mediated by the products of the bvg locus despite potential growthlimiting conditions. This argument is strengthened by the results in Fig. 3 , which demonstrate modulation of AC expression in vitro by the bacteria even under limiting growth conditions. It is certainly possible that the stimulus for this down-modulation is contained within the milieu of the endocytic vesicles of the macrophage encountered by the bacteria with internalization.
Survival of B. pertussis upon challenge with human macrophages has been attributed to expression of adhesins and virulence factors in the Vir+ state (39) . If the regulatory circuit between the bvg and the cya loci serves as a paradigm for gene regulation of other members of the vir regulon, then the results reported here suggest that the natural progression of events in the disease may require that B. pertussis phenotypically changes to a Vir-state upon entry into the macrophage. This hypothesis is supported by studies with animal models for the disease. A mutant with a transposon insertion in vrg6 (a vir-repressed gene) was less able to colonize the lung and trachea in a mouse model for respiratory infection (40) . Similar studies also demonstrated that the AC (the product ofa vir-activated gene) is absolutely required for colonization (41) . Therefore, B. pertussis has developed a survival strategy based on the coordinate regulation of genes including the cya operon that results in two distinct phenotypes. In the Vir+ state the bacteria adhere and colonize the host in several niches. Thereafter access to another environment, the alveolar macrophage, leads to the Virstate, cessation of toxin production, and establishment of intracellular bacteria that remain sequestered from host defenses. The ability of the bacteria to sense its environment and switch between two phenotypes confers a selective advantage for B. pertussis in promoting successful and persistent survival within the host.
